SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001100682-22-000010
Filing Date
2022-03-28
Accepted
2022-03-28 08:55:44
Documents
12
Period of Report
2022-03-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K crl-20220328.htm   iXBRL 8-K 39941
  Complete submission text file 0001100682-22-000010.txt   177823

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crl-20220328.xsd EX-101.SCH 1897
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crl-20220328_lab.xml EX-101.LAB 24132
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crl-20220328_pre.xml EX-101.PRE 12509
6 EXTRACTED XBRL INSTANCE DOCUMENT crl-20220328_htm.xml XML 10826
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Filer) CIK: 0001100682 (see all company filings)

IRS No.: 061397316 | Fiscal Year End: 1225
Type: 8-K | Act: 34 | File No.: 001-15943 | Film No.: 22773323
SIC: 8731 Services-Commercial Physical & Biological Research